Lifecore Biomedical Inc (NAS:LFCR)
$ 7.6 0.57 (8.11%) Market Cap: 279.88 Mil Enterprise Value: 411.23 Mil PE Ratio: 152.00 PB Ratio: 0 GF Score: 69/100

Q4 2024 Lifecore Biomedical Inc Earnings Call Transcript

Aug 27, 2024 / 12:30PM GMT
Release Date Price: $4.74 (-25.24%)
Operator

Greetings, and welcome to the Lifecore Biomedical Q4 and full-year 2024 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to introduce your host, Stephanie Diaz, Investor Relations. Stephanie, please go ahead.

Stephanie Diaz
Vida Strategic Partners - Investor Relations

Good morning, and thank you for joining us today to discuss Lifecore Biomedical fourth quarter and full year fiscal 2024 earnings results. Hosting the call today from the company are Paul Josephs, President and CEO; and John Morberg, Chief Financial Officer.

Before we begin today, we'd like to remind everyone of the Safe Harbor statement. Certain statements made in the course of this conference call contain forward looking statements. It is important to note that the company's actual results could differ materially from those projected in such forward-looking statements.

Additional information concerning risk factors that could cause actual results to differ materially from those in the forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot